This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Obesity is one of the top risk factors within the spectrum of serious diseases that constitute metabolic syndrome. A team of the Tumour Supression Group at the CNIO could reduce it in animal models using a drug which inhibits the activity of the PI3K enzyme.